Form C - Offering Statement:
SEC Accession No. 0001139685-25-000005
Filing Date
2025-05-20
Accepted
2025-05-20 17:22:52
Documents
7

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11905
2 offering_statement.pdf EX-99 1234902
3 exhibit_a.pdf EX-99 711830
4 exhibit_b.pdf EX-99 1687676
5 exhibit_c.pdf EX-99 446524
6 exhibit_e.pdf EX-99 343165
7 exhibit_d.pdf EX-99 8000978
  Complete submission text file 0001139685-25-000005.txt   17123442
Mailing Address 15810 GAITHER ROAD, SUITE 235 SUITE 235 GAITHERSBURG MD 20877
Business Address 9430 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 2404536339
20/20 Biolabs, Inc. (Filer) CIK: 0001139685 (see all company filings)

EIN.: 522272107 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-35925 | Film No.: 25970063
SIC: 8734 Services-Testing Laboratories
(CF Office: 08 Industrial Applications and Services)